Somatostatin receptor scintigraphy in small-cell lung cancer: Results of a multicenter study

Journal of Nuclear Medicine

Volumn 39, Issue 2, 1998, Pages 224-227

  Reisinger, Ingrid ^a   Bohuslavitzki, Karl Heinz ^b   Brenner, Winfried ^b   Braune, Simone ^b   Dittrich, Ina ^b   Geide, Axel ^b   Kettner, Beatrice ^b   Otto, Hans Jürgen ^b   Schmidt, Sylvia ^b   Munz, Dieter L ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b NONE

Author keywords

Octreotide; Sensitivity; Small cell lung cancer; Uptake

Indexed keywords

PENTETREOTIDE; PENTETREOTIDE IN 111; SOMATOSTATIN RECEPTOR;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; HUMAN TISSUE; LIVER METASTASIS; LUNG SCINTISCANNING; LUNG SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM LYMPH NODE; MULTICENTER STUDY; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; AGED; CARCINOMA, SMALL CELL; FEMALE; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; OCTREOTIDE; PENTETIC ACID; RADIOPHARMACEUTICALS; RECEPTORS, SOMATOSTATIN; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 17944404297     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Niederle N, Weidmann B. Kleinzelliges bronchialkarzinom. In: Zeller WJ, ed. Onkologie: Grundlagen, Diagnostik, Therapie, Entwicklungen, 1st ed. Landsberg, Germany: Lech Ecomed; 1995:1-11.
2. Schulz V, Zeidler D, Adolph J, zum Winkel K. Bronchopulmonale Tumoren. In: Ferlinz R, ed. Pneumologie in Praxis und Klinik. Stuttgart, Germany: Georg Thieme Verlag; 1994:646-702.
3. Stokkel MPM, Kwa BH, Pauwels EKJ. Imaging and staging of small-cell lung cancer: is there a future role for octreotide scintigraphy? Br J Clin Pract 1995;49:235-238.
4. Prevost G, Bourgeois Y, Mormont C, et al. Characterization of somatostatin receptors and growth inhibition by the somatostatin analogue BIM23014 in small cell lung carcinoma xenograft: SCLC-6. Life Sci 1994;55:155-162.
5. Taylor JE, Theveniau MA, Bashirzadeh R, Reisine T, Eden PA. Detection of somatostatin receptor subtype 2 (SSTR 2) in established tumors and tumor cell lines: evidence for SSTR 2 heterogeneity. Peptides 1994;15:1229-1236.
6. Kwekkeboom DJ, Krenning E, Bakker WH, Oei HY, Splinter TWA, Lamberts SWJ. Radioiodinated somatostatin analog scintigraphy in small-cell lung cancer. J Nucl Med 1991;32:1845-1848.
7. 123I-Tyr)-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med 1993;20:716-731.
8. Leitha T, Meghdadi S, Studnicka M, et al. The role of iodine-123-Tyr-3-octreotide scintigraphy in the staging of small-cell-lung cancer. J Nucl Med 1993;34:1397-1402.
9. 111In-DTPA-octreotide: a preliminary study. Nucl Med Commun 1993; 14:962-968.
10. 111In]pentetreotide, a radiolabelled somatostatin analogue. Br J Cancer 1994;69:762-766.
11. Kirsch CM, von Pawel J, Grau I, Tatsch K. In-111 pentetreotide in diagnostic work-up of patients with bronchogenic carcinoma. Eur J Nucl Med 1994;21:1318-1325.
12. Kwekkeboom DJ, Kho GS, Lamberts SW, Reubi JC, Laissue JA, Krenning EP. The value of octreotide scintigraphy in patients with lung cancer. Eur J Nucl Med 1994;21:1106-1113.
13. Reisinger I, Kettner B, Witt C, Ivancevic V. Somatostatin receptor scintigraphy (SRS) of small-cell lung cancer (SCLC) [Abstract]. Eur J Nucl Med 1995;22:845.
14. Schmidt S, Alexander C, Höfer M, Ukena D, Oberhausen E. Somatostatinrezeptorszintigraphie mit In-111-Octreoscan beim kleinzelligen Bronchialkarzinom [Abstract]. Nucl Med 1995;34:A150.
15. Eberhardt JU, Günther M, Bohuslavitzki KH, et al. Stellenwert der Octreotid-szintigraphie beim kleinzelligen Bronchialkarzinom im Vergleich zu anderen bildgebenden Verfahren [Abstract]. Nuklearmedizin 1995;34:A151.
16. Kettner B, Reisinger I, John M, Witt C, Munz DL. Somatostatin-Rezeptor-Szintigraphie (SRS) beim kleinzelligen Bronchialkarzinom [Abstract]. Nucl Med 1995;34: A151.
17. Braune S, Dittrich K, Otto HJ, Liebtrau G, Bentrup A, Hundeshagen H. Somatostatinrezeptorszintigraphie beim kleinzelligen Bronchialkarzinom (SCLC). Staging und Verlaufskontrolle [Absract]. Nucl Med 1995;34:A150.
18. 111In DTPA-octreotide scintigraphy. Eur J Cancer 1995; 31A:184-188.
19. Bohuslavitzki KH, Brenner W, Günther M, et al. Somatostatin receptor scintigraphy in the staging of small cell lung cancer. Nucl Med Commun 1996;17:191-196.
20. O'Byrne KJ, Carney DN. Somatostatin and the lung. Lung Cancer 1993;10:151-172.
21. Fujita T, Yamaji Y, Sato M, Murao K, Takahara J. Gene expression of somatostatin receptor subtypes, SSTR 1 and SSTR 2, in human lung cancer cell lines. Life Sci 1994;55:1797-1806.
22. Kwekkeboom DJ, Lamberts SWJ, Habbema JDF, Krenning EP. Cost-effectiveness analysis of somatostatin receptor scintigraphy. J Nucl Med 1996;37:886-892.
23. Reubi JC, Horisberger U, Laissue J. High density of somatostatin receptor in veins surrounding human cancer tissue: role in tumor-host action? Int J Cancer 1994;56: 681-688.
24. Lamberts SWJ, Krenning EP, Reubi J-C. The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocr Rev 1991;12:450-482.
25. Sreedharan SP, Kodama KT, Peterson KE, Goetzl EJ. Distinct subsets of somatostatin receptors on cultured human lymphocytes. J Biol Chem 1989;264:949-952.
26. Vanhagen PM, Krenning EP, Reubi JC, et al. Somatostatin analogue scintigraphy in granulomatous diseases. Eur J Nucl Med 1994;21:497-502.
27. Weckbecker G, Raulf F, Stolz B, Bruns C. Somatostatin analogs for diagnosis and treatment of cancer. Pharmacol Ther 1993;60:245-264.
28. Herder WW, Van der Lely AJ, Lamberts SWJ. Somatostatin analogue treatment of neuroendocrine tumors. Postgrad Med J 1996;72:403-408.